CRISPR Therapeutics AG (NASDAQ:CRSP) currently has a daily average trading volume of 2.01M but it saw 1632951 shares traded in last market. With a market cap of 3.21B USD, the company’s current market price of $37.22 came falling about -0.92 while comparing to the previous closing price of $37.57. In past 52 weeks, the stock remained buoying in the range of price level as high as $67.88 and as low as $30.04. In the recent trading on the day, stock has struck highest price mark of $37.165 while lowest mark touched by it was $38.125.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Evercore ISI which upgraded the stock as “Outperform” in its note to investors issued on February 14, 2025, recommending a price target of between $60 and $99 for it. TD Cowen upgraded its recommendation for the stock as a “Hold” from “Sell” on February 12, 2025 while assigning a price target of $35. H.C. Wainwright issued its recommendations for the stock as it initiated the price target for the stock is $65.
Over the week, CRSP’s stock price is moving -5.16% down while it is -1.73% when we observe its performance for the past one month. Year-to-date it is -5.42% down and over the past year, the stock is showing a downside performance of -33.20%.
Currently, CRISPR Therapeutics AG’s total number of outstanding shares is 86.36M with 1.75% of that held by the insiders while 76.60% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -18.99% and return on equity (ROE) at -19.71%. Stock’s beta reads 1.76. Stock has a price to book (P/B) ratio of 1.76 while price to sale or P/S ratio amounts to 85.34. Its return on asset (ROA) is -16.75% on average.
